Compared to high income cities, less developed cities in Brazil have a higher hospitalization rate associated with increased heat exposure, according to a new study published this week in PLOS Medicine by Yuming Guo of the Monash University, Australia, and colleagues.
Heat exposure, which will increase with global warming, is associated with increases in mortality and morbidity but little is known about the socioeconomic disparities in vulnerability to heat. In the new study, researchers collected daily hospitalization and climate data in the hot season during 2000 through 2015 from 1,814 Brazilian cities covering 78.4% of the Brazilian population. 49 million hospitalizations were studied.
For cities of lower middle income, as classified by the World Bank, every 5°C increase in daily mean temperature during the hot season was associated with 5.1% (95%CI 4.4-5.7, p<0.001) increase in all-cause hospitalization. For cities of middle income, every 5°C temperature increase was associated with a 3.7% (95%CI 3.3-4.0, p<0.001) increase in hospitalization. While for cities of high income, the temperature increase was only associated with a 2.6% (95%CI 1.7-3.4, p<0.001) increase in hospitalization. The inter-city disparities in the association were strongest for children and adolescents, and the disparities were particularly evident for certain diseases including heart disease, asthma, pneumonia, renal diseases, mental health conditions and neoplasms.
“Increasing heat exposure along with global warming could be a potential driver for exacerbating inter-city health inequalities,” the authors say. “More attention should be paid to less developed cities in Brazil to tackle the morbidity burden of heat exposure, in order to promote health equity under a global warming trend.”
#####
Funding: R.X. was supported by China Scholarship Council (201806010405). S.L. was supported by an Early Career Fellowship of the Australian National Health and Medical Research Council (APP1109193). Y.G. was supported by a Career Development Fellowship of the Australian National Health and Medical Research Council (APP1107107 & APP1163693). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: MA holds investigator initiated grants from Pfizer and Boehringer-Ingelheim for unrelated research and an unrelated consultancy from Sanofi. He has also received assistance with conference attendance from Sanofi and a speaker’s fee from GSK. YG is an Academic Editor on PLOS Medicine’s editorial board. The other authors declare no actual or potential competing interests.
About PLOS Medicine
PLOS Medicine publishes articles on biomedical, environmental, social and political determinants of human health worldwide. The journal accepts a variety of study designs including clinical trials, observational studies, diagnostic and prognostic tools, epidemiology, predictive and explanatory modeling, qualitative studies and clinically oriented translational research. For more information, visit http://journals.plos.org/plosm
Media and Copyright Information
For information about PLOS Medicine relevant to journalists, bloggers and press officers, including details of our press release process and embargo policy, visit http://journals.plos.org/plosm
PLOS journals publish under a Creative Commons Attribution License, which permits free reuse of all materials published with the article, so long as the work is cited.
About the Public Library of Science
Public Library of Science (PLOS) is a nonprofit Open Access (OA) publisher, innovator and advocacy organization dedicated to accelerating progress in science and medicine by leading a transformation in research communication. The PLOS suite of journals contain rigorously peer-reviewed Open Access research articles from all areas of science and medicine, together with expert commentary and analysis. In addition to journals, the organization advances innovations in scientific publishing through Collections, Communities and The PLOS Blog Network. Founded to catalyze a revolution in scientific publishing by demonstrating the value and feasibility of Open Access publication, PLOS is committed to innovative and forward-looking solutions to scientific communication. For more information, visit https://www.plos.org/who-we-ar
